Jiang Qinglong, Zhang Xi, Wang Chao, Qin Rong, Sun Rui, Qin Shengling, Zhao Cong, Li Zhiyong, Zhu Wenjie, Cong Minghua
Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Curr Oncol. 2025 Apr 23;32(5):245. doi: 10.3390/curroncol32050245.
The aim of this study was to analyze the clinical characteristics and prognostic factors of profound hyponatremia in solid cancer patients admitted to the oncologic emergency department.
We gathered data retrospectively from cancer patients who visited the emergency department of the National Cancer Center of China between October 2019 and February 2023 with a serum sodium (Na) level of less than 125 mmol/L. The demographic and clinical characteristics, medical history, admission symptoms, laboratory parameters, and outcomes of the patients were recorded.
This study comprised 307 patients with severe hyponatremia in total. With 39.4% of all tumors being lung cancer ( = 121), nausea and vomiting were the most common admission symptoms for patients with severe hyponatremia. The 30-day mortality rate of profound hyponatremia cancer patients in the emergency department was 13.4%. The albumin level ( < 0.001), the hemoglobin level ( = 0.033), the TNM stage ( = 0.004), the Eastern Cooperative Oncology Group Performance Status (ECOG-PS) score ( < 0.001), hypocalcemia ( = 0.006), renal insufficiency ( = 0.035), and the efficacy of sodium supplementation ( = 0.006) were significantly associated with 30-day mortality. Binary logistic regression analysis showed that a lower albumin level (OR 0.924, 95% CI 0.861-0.991, = 0.028) and higher ECOG score (OR 8.443, 95% CI 3.568-19.976, < 0.001) were independent risk factors for 30-day mortality. The overall survival of emergency cancer patients with severe hyponatremia was also examined. The results of the COX regression analysis demonstrated that the efficacy of sodium supplementation (OR = 2.643, 95% CI 1.593-4.386, < 0.001), a low albumin level (OR = 0.654, 95% CI 0.463-0.923, = 0.016), the TNM stage (OR = 4.606, 95% CI 2.846-7.455), and a higher ECOG score (OR = 1.738, 95% CI 1.292-2.338, < 0.001) were independent risk factors for overall survival.
The clinical manifestations of severe hyponatremia in emergency cancer patients are varied. Hypoalbuminemia and a higher ECOG score are independent risk factors for 30-day mortality and overall survival. Severe hyponatremia patients with a high ECOG score and/or a low albumin level should be monitored and followed more closely.
本研究旨在分析入住肿瘤急诊科的实体癌患者严重低钠血症的临床特征及预后因素。
我们回顾性收集了2019年10月至2023年2月期间就诊于中国国家癌症中心急诊科、血清钠(Na)水平低于125 mmol/L的癌症患者的数据。记录患者的人口统计学和临床特征、病史、入院症状、实验室参数及转归。
本研究共纳入307例严重低钠血症患者。所有肿瘤中39.4%为肺癌(n = 121),恶心和呕吐是严重低钠血症患者最常见的入院症状。急诊科严重低钠血症癌症患者的30天死亡率为13.4%。白蛋白水平(P < 0.001)、血红蛋白水平(P = 0.033)、TNM分期(P = 0.004)、东部肿瘤协作组体能状态(ECOG-PS)评分(P < 0.001)、低钙血症(P = 0.006)、肾功能不全(P = 0.035)及补钠疗效(P = 0.006)与30天死亡率显著相关。二元logistic回归分析显示,较低的白蛋白水平(OR 0.924,95%CI 0.861 - 0.991,P = 0.028)和较高的ECOG评分(OR 8.443,95%CI 3.568 - 19.976,P < 0.001)是30天死亡率独立危险因素。还对急诊科严重低钠血症癌症患者的总生存情况进行了研究。COX回归分析结果表明,补钠疗效(OR = 2.643,95%CI 1.593 - 4.386,P < 0.001)、低白蛋白水平(OR = 0.654,95%CI 0.463 - 0.923,P = 0.016)、TNM分期(OR = 4.606,95%CI 2.8